NRS
CVS icon

Neville Rodie & Shaw’s CVS Health CVS Stock Holding History

Neville Rodie & Shaw’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,141
Closed -$1.9M – 261
2024
Q3 		$1.9M Sell
30,141
-35,403
-54% -$2.07M 0.14% 95
2024
Q2 		$3.87M Sell
65,544
-4,591
-7% -$287K 0.29% 66
2024
Q1 		$5.59M Sell
70,135
-13,446
-16% -$1.03M 0.43% 56
2023
Q4 		$6.6M Sell
83,581
-2,923
-3% -$208K 0.54% 43
2023
Q3 		$6.04M Sell
86,504
-750
-0.9% -$53.1K 0.54% 46
2023
Q2 		$6.03M Sell
87,254
-185
-0.2% -$13.2K 0.52% 47
2023
Q1 		$6.5M Sell
87,439
-325
-0.4% -$27.3K 0.59% 44
2022
Q4 		$8.18M Sell
87,764
-6,350
-7% -$613K 0.77% 37
2022
Q3 		$8.97M Sell
94,114
-150
-0.2% -$14.8K 0.88% 35
2022
Q2 		$8.73M Sell
94,264
-775
-0.8% -$75.6K 0.78% 39
2022
Q1 		$9.61M Sell
95,039
-246
-0.3% -$25.8K 0.71% 43
2021
Q4 		$9.83M Sell
95,285
-1,950
-2% -$180K 0.7% 39
2021
Q3 		$8.25M Sell
97,235
-249
-0.3% -$20.9K 0.64% 46
2021
Q2 		$8.13M Sell
97,484
-237
-0.2% -$19.4K 0.63% 47
2021
Q1 		$7.35M Buy
97,721
+725
+0.7% +$52.8K 0.61% 47
2020
Q4 		$6.63M Sell
96,996
-824
-0.8% -$53.6K 0.57% 46
2020
Q3 		$5.71M Sell
97,820
-19,725
-17% -$1.23M 0.54% 49
2020
Q2 		$7.64M Buy
117,545
+1,725
+1% +$109K 0.79% 43
2020
Q1 		$6.87M Buy
115,820
+9,857
+9% +$658K 0.84% 41
2019
Q4 		$7.87M Buy
105,963
+7,050
+7% +$495K 0.77% 43
2019
Q3 		$6.24M Buy
98,913
+43,100
+77% +$2.55M 0.66% 50
2019
Q2 		$3.04M Buy
+55,813
New +$3.01M 0.32% 77

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Neville Rodie & Shaw's CVS Position: Q4 2024 in Review

Neville Rodie & Shaw sold out of CVS Health (CVS) in Q4 2024, closing a stake of 30,141 shares — an estimated $1.9M sold.

Neville Rodie & Shaw first reported a position in CVS in Q2 2019 and held it in 22 quarters. The position peaked at $9.83M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Neville Rodie & Shaw reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Neville Rodie & Shaw sold 30,141 CVS Health shares in Q4 2024, an estimated $1.9M.
  • Neville Rodie & Shaw first reported a position in CVS Health in Q2 2019 and held it in 22 quarters.
  • Neville Rodie & Shaw's CVS Health position peaked at $9.83M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Neville Rodie & Shaw's 13F filing for Q4 2024, filed 6 Jan 2025.